๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

โœ Scribed by Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Richard F.; Sosman, Jeffrey; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Ibrahim, Nageatte; Kudchadkar, Ragini; Burris, Howard A.; Falchook, Gerald; Algazi, Alain; Lewis, Karl; Long, Georgina V.; Puzanov, Igor; Lebowitz, Peter; Singh, Ajay; Little, Shonda; Sun, Peng; Allred, Alicia; Ouellet, Daniele; Kim, Kevin B.; Patel, Kiran; Weber, Jeffrey

Book ID
118256722
Publisher
Massachusetts Medical Society
Year
2012
Tongue
English
Weight
528 KB
Volume
367
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combined BRAF and MEK Inhibition in Mela
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
โœ Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Ri ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Massachusetts Medical Society ๐ŸŒ English โš– 528 KB

## Background Resistance to therapy with BRAF kinase inhibitors is associated with reactivation of the mitogen-activated protein kinase (MAPK) pathway. To address this problem, we conducted a phase 1 and 2 trial of combined treatment with da braf e nib, a selective BRAF inhibitor, and trametinib, a

Detection of BRAF V600 Mutations in Meta
Detection of BRAF V600 Mutations in Metastatic Melanoma
โœ Qu, Kevin; Pan, Qiulu; Zhang, Xi; Rodriguez, Luis; Zhang, Ke; Li, Hairong; Ho, A ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› American Society for Investigative Pathology ๐ŸŒ English โš– 527 KB